Suppr超能文献

牙科手术中使用口服抗凝剂患者的出血风险:一项系统评价和荟萃分析。

Bleeding Risk in Patients Using Oral Anticoagulants Undergoing Surgical Procedures in Dentistry: A Systematic Review and Meta-Analysis.

作者信息

de Andrade Natália Karol, Motta Rogério Heládio Lopes, Bergamaschi Cristiane de Cássia, Oliveira Luciana Butini, Guimarães Caio Chaves, Araújo Jimmy de Oliveira, Lopes Luciane Cruz

机构信息

Division of Pharmacology, Anesthesiology and Therapeutics, Faculdade São Leopoldo Mandic, Instituto de Pesquisas São Leopoldo Mandic, Campinas, Brazil.

Pharmaceutical Science Graduate Course, University of Sorocaba, Sorocaba, Brazil.

出版信息

Front Pharmacol. 2019 Aug 9;10:866. doi: 10.3389/fphar.2019.00866. eCollection 2019.

Abstract

The management of patients who undergo dental surgical procedures and receive oral anticoagulant therapy requires particular attention due to the risk of bleeding that may occur during the procedure. Bleeding rates in these trans- or post-operative patients tend to be unpredictable. The aim of this study was to conduct a systematic review in order to assess the risk of bleeding during and after performing oral surgery in patients administered oral anticoagulants compared with a group that discontinued anticoagulant therapy. For the purposes of this review, we searched the databases of the Cochrane Central Register of Controlled Trials (CENTRAL), MEDLINE ( Ovid), EMBASE ( Ovid), and the Virtual Health Library (VHL) from inception of the database to December 2018. The primary outcome was defined as the occurrence of local bleeding during and after oral surgical procedures. Four reviewers, independently and in pairs, screened titles and abstracts for full-text eligibility. Data regarding participant characteristics, interventions, and design and outcomes of the included studies were extracted. The data were pooled using random-effects meta-analyses and described as risk ratios (RRs) with a 95% confidence interval (95% CI). The confidence for the pooled estimates was ascertained through the Grading of Recommendations Assessment, Development, and Evaluation (GRADE) approach, and the protocol of this review was recorded in PROSPERO (CRD42017056986). A total of 58 eligible studies were identified, of which three randomized controlled trials were included in the meta-analysis, covering a total of 323 adult participants, among whom 167 were taking anticoagulants at the time they underwent dental surgery. Of these patients, 14.2% had reported bleeding. The risk of bleeding was found to be one to almost three times greater in patients taking warfarin compared with patients who discontinued the use of anticoagulant during the trans-operative period (RR = 1.67, 95% CI = 0.97 to 2.89) and in the post-operative period (RR = 1.44, 95% CI = 0.71 to 2.92), although the quality of evidence was very low. The results indicate that there is no evidence that the use of anticoagulants eliminates the risk of bleeding during surgical dental procedures.

摘要

接受牙科手术并接受口服抗凝治疗的患者的管理需要特别关注,因为手术过程中可能会发生出血风险。这些手术中或术后患者的出血率往往不可预测。本研究的目的是进行系统评价,以评估与停用抗凝治疗的组相比,接受口服抗凝剂的患者在进行口腔手术期间及术后的出血风险。为了本次评价,我们检索了Cochrane对照试验中心注册库(CENTRAL)、MEDLINE(Ovid)、EMBASE(Ovid)和虚拟健康图书馆(VHL)的数据库,检索时间从数据库建立至2018年12月。主要结局定义为口腔外科手术期间及术后局部出血的发生情况。四名评价者独立且两两一组地筛选标题和摘要以确定是否符合全文纳入标准。提取了有关纳入研究的参与者特征、干预措施、设计和结局的数据。使用随机效应荟萃分析对数据进行合并,并描述为风险比(RRs)及95%置信区间(95%CI)。通过推荐分级的评估、制定和评价(GRADE)方法确定合并估计值的可信度,本评价方案记录在国际前瞻性注册系统(PROSPERO,注册号:CRD42017056986)中。共识别出58项符合条件的研究,其中三项随机对照试验纳入了荟萃分析,共涵盖323名成年参与者,其中167人在接受牙科手术时正在服用抗凝剂。在这些患者中,14.2%报告有出血情况。结果发现,与在手术期间停用抗凝剂的患者相比,服用华法林的患者在手术期间(RR = 1.67,95%CI = 0.97至2.89)和术后(RR = 1.44,95%CI = 0.71至2.92)出血风险高出1至近3倍,尽管证据质量非常低。结果表明,没有证据表明使用抗凝剂可消除牙科手术期间的出血风险。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4a9c/6696826/73102f2ed89f/fphar-10-00866-g001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验